Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Driving competences and neuropsychological factors associated to driving counseling in multiple sclerosis.
Myelination: Do Astrocytes Play a Role?
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain.
Patient Characteristics Associated with Medication Adherence.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Surgical Outcomes of Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Pages
« first
‹ previous
…
341
342
343
344
345
346
347
348
349
…
next ›
last »